C
IBRX icon

Covestor’s ImmunityBio IBRX Stock Holding History

Covestor’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
1,133
+1,073
+1,788% +$8.12K 0.01% 1589
2026
Q1 		$0 Buy
60
+1
+2% +$7 ﹤0.01% 2498
2025
Q4 		$0 Sell
59
-1
-2% -$2 ﹤0.01% 2473
2025
Q3 		$0 Hold
60
– – ﹤0.01% 2494
2025
Q2 		$0 Sell
60
-4
-6% -$11 ﹤0.01% 2446
2025
Q1 		$0 Buy
64
+29
+83% +$88 ﹤0.01% 2450
2024
Q4 		$0 Buy
35
+2
+6% +$8 ﹤0.01% 2461
2024
Q3 		$0 Sell
33
-2
-6% -$9 ﹤0.01% 2442
2024
Q2 		$0 Hold
35
– – ﹤0.01% 2460
2024
Q1 		$0 Sell
35
-43
-55% -$195 ﹤0.01% 2457
2023
Q4 		$0 Buy
78
+41
+111% +$129 ﹤0.01% 2378
2023
Q3 		$0 Sell
37
-5
-12% -$10 ﹤0.01% 2363
2023
Q2 		$0 Sell
42
-1
-2% -$3 ﹤0.01% 2358
2023
Q1 		$0 Hold
43
– – ﹤0.01% 2273
2022
Q4 		$0 Sell
43
-2
-4% -$11 ﹤0.01% 2292
2022
Q3 		$0 Sell
45
-9
-17% -$41 ﹤0.01% 2259
2022
Q2 		$0 Sell
54
-15
-22% -$60 ﹤0.01% 2116
2022
Q1 		$0 Sell
69
-15
-18% -$92 ﹤0.01% 2256
2021
Q4 		$1K Buy
+84
New +$631 ﹤0.01% 1784

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Covestor's IBRX Position: Q2 2026 in Review

Covestor increased its ImmunityBio (IBRX) stake by 1,788% in Q2 2026, buying an estimated $8.12K and bringing the position to 1,133 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1589.

Covestor first reported a position in IBRX in Q4 2021 and has held it in 19 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Covestor held 1,133 shares of ImmunityBio worth $10K as of Q2 2026.
  • Covestor bought 1,073 ImmunityBio shares in Q2 2026, an estimated $8.12K.
  • ImmunityBio made up 0.01% of Covestor's portfolio in Q2 2026, its #1589 holding.
  • Covestor first reported a position in ImmunityBio in Q4 2021 and has held it in 19 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.